Myelodysplastic Syndrome Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Suspended
  • Acute Myeloid Leukemia
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center LAO
2021-10-14
Oct 14, 2021
N
Withdrawn
  • Myelodysplastic Syndrome
  • +4 more
  • UAE Inhibitor TAK-243
  • (no location specified)
2021-10-14
Oct 14, 2021
F
Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-10-13
Oct 13, 2021
N
Recruiting
  • Neoplasms
  • +3 more
    • Iowa City, Iowa
    • +6 more
    2021-10-13
    Oct 13, 2021
    N
    Recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • Rituximab
    • +6 more
    • Bethesda, Maryland
    • +1 more
    2021-10-09
    Oct 9, 2021
    A
    Terminated
    • Multiple Myeloma
    • +6 more
    • AMG 397
    • +2 more
    • Birmingham, Alabama
    • +20 more
    2021-10-08
    Oct 8, 2021
    M
    Completed
    • Leukemia
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2021-09-09
    Sep 9, 2021
    F
    Not yet recruiting
    • Acute Biphenotypic Leukemia
    • +5 more
    • Omidubicel
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-10-04
    Oct 4, 2021
    R
    Completed
    • Acute Myeloid Leukemia
    • +5 more
    • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    2021-10-04
    Oct 4, 2021
    M
    Active, not recruiting
    • High Risk Myelodysplastic Syndrome
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-09-02
    Sep 2, 2021
    F
    Recruiting
    • Acute Leukemia
    • +18 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-09-29
    Sep 29, 2021
    F
    Recruiting
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-09-27
    Sep 27, 2021
    S
    Completed
    • Myelodysplastic Syndrome
    • +13 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    2021-09-24
    Sep 24, 2021
    U
    Active, not recruiting
    • Hodgkin's Lymphoma
    • +8 more
    • Reduced intensity haplodentical stem cell transplant
    • Myeloablative haploidentical stem cell transplant
    • Birmingham, United Kingdom
    • +11 more
    2021-09-27
    Sep 27, 2021
    N
    Active, not recruiting
    • Anemia
    • +3 more
    • Epoetin Alfa
    • +2 more
    • Birmingham, Alabama
    • +512 more
    2021-09-25
    Sep 25, 2021
    M
    Recruiting
    • Myelodysplastic Syndrome
    • +16 more
    • Computed Tomography
    • +6 more
    • Scottsdale, Arizona
    • +2 more
    2021-09-24
    Sep 24, 2021
    P
    Active, not recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Birmingham, Alabama
    • +33 more
    2021-08-27
    Aug 27, 2021
    F
    Recruiting
    • Acute Erythroid Leukemia
    • +10 more
    • San Francisco, California
    • +4 more
    2021-09-17
    Sep 17, 2021